Responses
Neurology
Original research
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
Compose a Response to This Article
Other responses
No responses have been published for this article.